eCite Digital Repository

Idarubicin, cytarabine in standard or high-dose, and etoposide lenograstim (G-CSF) for adult acute myeloid leukemia (AML). Combinations giving high remission rates.

Citation

Lowenthal, RM and Bradstock, KM and Matthews, JP and Enno, A and Gill, D and Page, FJ and Rooney, KF and Taylor, KM, Idarubicin, cytarabine in standard or high-dose, and etoposide lenograstim (G-CSF) for adult acute myeloid leukemia (AML). Combinations giving high remission rates., American Society of Hematology 37th Annual Meeting, 1-5 December, Seattle, USA, pp. 768a. (1995) [Conference Extract]

Item Details

Item Type:Conference Extract
Research Division:Medical and Health Sciences
Research Group:Oncology and Carcinogenesis
Research Field:Oncology and Carcinogenesis not elsewhere classified
Objective Division:Health
Objective Group:Other Health
Objective Field:Health not elsewhere classified
Author:Lowenthal, RM (Professor Ray Lowenthal)
Author:Rooney, KF (Associate Professor Kim Rooney)
ID Code:5072
Year Published:1995
Deposited By:Clinical Sciences
Deposited On:1995-08-01
Last Modified:1996-02-01
Downloads:0

Repository Staff Only: item control page